Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initial Influenza Exposure and Immunity in Children
NCT02559505Completed
- Sponsor
- University of Rochester
- Start
- Oct 2015
- Primary completion
- Jul 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of Fluzone Trivalent in influenza (8 arms), sponsored by University of Rochester. Primary endpoint: Mean Percent of IFNg+ CD69+ CD4 T Cells Between Acute (H3N2) Infected and Vaccinated Subjects. Started Oct 2015; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02559505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559505.